How to Buy Janux Therapeutics Stock
Janux Therapeutics Inc
Janux Therapeutics, Inc. , a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer.
Janux Therapeutics stock last closed at $30.01, up 2.42% from the previous day, and has decreased 38.6% in one year. It has overperformed other stocks in the Biotechnology industry by 0.38 percentage points. Janux Therapeutics stock is currently +33.26% from its 52-week low of $22.52, and -58.15% from its 52-week high of $71.71.
There are currently 59.11M JANX shares outstanding. The market value of JANX is $1.77B. In the past 24 hours, 730,395 JANX shares were traded.
How to Buy Janux Therapeutics Stock
Wondering how to invest in Janux Therapeutics stock? Here's how.
- Figure out where to buy Janux Therapeutics stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Janux Therapeutics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Choose your method of payment and add your information.
- Research Janux Therapeutics stock: The Janux Therapeutics ticker symbol is JANX. Is Janux Therapeutics stock a good investment? Should you buy shares of JANX? How do JANX's underlying business fundamentals look? Do top analysts think Janux Therapeutics is a good buy? Why has JANX's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if JANX is a good stock to buy).
- Place your JANX purchase: Decide if you will purchase JANX shares at the current market price or use a limit order to buy JANX shares at a particular price.
- Watch your JANX position: Create a watchlist to key updates about your new investment in Janux Therapeutics stock.
Step 1: Figure out where to buy Janux Therapeutics stock
You need an online brokerage account in order to access the NASDAQ market and buy JANX stock.
Our favorite brokerage: eToro
We believe that eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected your brokerage, you need to fill out some personal information so you can invest in JANX stock today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open your new brokerage account.
- Submit your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've finished signing up on investing apps, you need to deposit funds:
Watch the tutorial below if you need help transferring funds into your brokerage account.
Step 4: Research Janux Therapeutics stock
Once you have decided on the best place to buy Janux Therapeutics stock, it's absolutely critical to research their stock before you buy, so you can comprehend the risk and opportunity.
Janux Therapeutics stock at a glance
JANX Due Diligence Checks
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on JANX's stock page.
Is JANX stock undervalued?
You can use many financial metrics, analyses, models, and charts to gauge JANX's fair value.
Using relative valuations metrics:
- JANX may be undervalued based on its P/B ratio of 1.73x, relative to Biotechnology industry P/B ratio of 4.16x
You can do additional valuation analysis on JANX's stock here.
A quick look at JANX Financials
Passed Financial Due Diligence Checks:
- JANX has cash burn of 44173000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the JANX balance sheet.
- Total JANX debt is lower than 5 years ago, relative to shareholder equity.
- JANX has $1.03B in cash and short term investments. This is enough to cover its annual cash burn of $44.17M.
- JANX has a low debt to equity ratio of 0.04.
- There are more short-term assets than short-term liabilities on the JANX balance sheet.
Failed Financial Due Diligence Checks:
- JANX profit margin has gone up by 0.7 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy Janux Therapeutics stock, according to analysts?
Out of 6 Wall Street analysts who research JANX, the consensus analyst rating on JANX is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
Most Recent JANX Analyst Upgrades/Downgrades
David Dai, a bottom 5% analyst from UBS initiates coverage on JANX with a strong buy rating and announces their JANX price target of $69.00, on Oct 24, 2024.
You can dig deeper into what analysts are projecting on the Janux Therapeutics stock forecast page.
JANX Momentum
Is JANX Growing Revenue?
Last year, JANX revenue was $10.59M. Over the last 3 year, JANX's revenue has grown by 124.1% per year. This was faster than the Biotechnology industry average of 44.4%.
Dive into JANX's earnings and revenue performance here.
What are JANX insiders up to?
Over the last 12 months, executives and large shareholders at JANX have sold more shares than they have bought.
Ra Capital Management LP, Director of JANX, was the latest JANX insider to buy. They bought $3,418,590.12 worth of JANX stock on Mar 7, 2025.
Get more info about who owns JANX stock here.
Can I rely on JANX as an income stream?
No, Janux Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about JANX?
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your JANX purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally the easiest way to buy. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given price limit, use a limit order.
Click the Open Trade button and eToro will execute your order.
If you need more help with buying stocks on eToro, click the helpful video below:
Step 6: Watch your JANX position
Now that you own some shares in JANX, you'll want to keep up with your investment.
Put JANX on a watchlist to track the latest developments regarding your JANX stock.
JANX Feed
How to Buy Stock in Janux Therapeutics
To reiterate, here are the 6 steps to buy Janux Therapeutics stock:
- Figure out where to buy Janux Therapeutics stock
- Open your brokerage account
- Deposit funds into your investment account
- Research Janux Therapeutics stock
- Place your JANX purchase
- Watch your JANX position
If you are looking for a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep an eye on your new investment in Janux Therapeutics, click the button below.
Other Content You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.